Summary
The Faculty of Pharmacy at the University of Helsinki invites applications for a Doctoral Researcher position to assess the immunogenic response of oncolytic virus nanoplatforms in glioblastoma treatment. This position is funded by the Doctoral Network project “INTRABRAIN” of the Horizon-Marie Skłodowska-Curie Actions (MSCA).
Doctoral Researcher (MSCA) Position: Immunogenic Response of Oncolytic Virus Nanoplatforms in Glioblastoma Treatment, University of Helsinki, Finland
Designation
Doctoral Researcher
Research Area
- Immunogenic Cell Death (ICD)
- Nanomedicine
- Oncology
- Immuno-Virotherapy
Location
University of Helsinki, Finland
Secondments at:
- University of Naples Federico II, Italy
- University of Rome Tor Vergata, Italy
Eligibility/Qualification
| Criteria | Details |
|---|---|
| Education | Master’s degree in Pharmaceutical Sciences, Biotechnology, Biomedical Engineering, Nanotechnology, Pharmacy, or related fields. |
| Research Experience | Must be in the first four years of full-time equivalent research career and have not yet been awarded a doctoral degree. |
| Mobility Rule | Must not have resided or carried out main activity (work/studies) in Finland for more than 12 months within the last 3 years prior to recruitment. |
| Language Proficiency | Proven proficiency in English (written and spoken). |
Job Description
The selected PhD candidate will:
- Investigate the immunogenic cell death induced by NanorADV-IL-12.
- Analyze mechanisms of tumor cell killing and immune responses in preclinical models.
- Collaborate with partner institutions on circulatory vesicular studies.
- Address technical challenges related to vesicle quantification and immunological monitoring.
- Utilize advanced analytical techniques and optimize experimental protocols.
How to Apply
Submit your application as a single PDF file through the University of Helsinki Recruitment System. The application must include:
- INTRABRAIN DC application form
- CV (max 2 pages)
- Cover letter (max 1 page)
- Certificate of Master’s Degree and transcript of records
- Proof of English proficiency
- Contact details of 2 referees
- List of publications and manuscripts (if applicable)
More Information on Application Process
Last Date for Apply
May 28, 2026, at 23:59 (Europe/Helsinki time)
